Dong-Gu Kim
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation (NCT02125071) | Dong-Gu Kim | 2013-11-01 |
Track Dong-Gu Kim automatically
Every clearance here is in the API, with alerts when new ones post.